STOCK TITAN

Ambiq Micro CTO Scott McLean Hanson sells 7,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Ambiq Micro, Inc. (AMBQ) Chief Technology Officer Scott McLean Hanson exercised options for 7,000 common shares at $8.12 per share on November 16, 2026, then sold 7,000 shares in three transactions. The sales comprised 4,084 shares at a weighted average price of $43.848, 2,900 at a weighted average price of $44.2921, and 16 at $45.12. The first two sales were reported within price ranges of $43.11–$44.09 and $44.11–$44.71, respectively.

The transactions were under a Rule 10b5-1 plan adopted May 15, 2026. The reported option position following the transaction was 31,279 shares.

Insider Hanson Scott McLean
Role Chief Technology Officer
Sold 7,000 shs ($308K)
Approx. gross sale proceeds $308K
Approx. exercise cost $57K
Approx. pre-tax spread $251K
Share of Position Sold 3.2%
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F4 7,000 $0.00 $0.00
Exercise Common Stock F1 7,000 $8.12 $57K
Sale Common Stock F1, F2 4,084 $43.848 $179K
Sale Common Stock F1, F3 2,900 $44.2921 $128K
Sale Common Stock F1 16 $45.12 $721.92
Holdings After Transaction: Stock Option (Right to Buy) — 31,279 options (Direct); Common Stock — 212,546 shares (Direct)
Holdings Before and After: Stock Option (Right to Buy), 38,279 to 31,279 options (Direct); Common Stock, 212,546 to 212,546 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
  1. F1. The transactions reported in this Form 4 occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026.
  2. F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.11 to $44.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.11 to $44.71 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. 1/4 of the shares subject to the option vested on August 16, 2019, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Options exercised for common shares 7,000 shares November 16, 2026
Option exercise price $8.12 per share Exercise reported November 16, 2026
Shares sold 7,000 shares November 16, 2026, across three sale entries
Weighted average sale price $43.848 per share 4,084 shares; reported sale prices ranged from $43.11 to $44.09 on November 16, 2026
Weighted average sale price $44.2921 per share 2,900 shares; reported sale prices ranged from $44.11 to $44.71 on November 16, 2026
Sale price $45.12 per share 16 shares sold November 16, 2026
Reported option position following transaction 31,279 shares Following the transaction reported November 16, 2026
Rule 10b5-1 plan regulatory
"the transactions occurred under a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"the reported price is a weighted average sale price"
Stock Option (Right to Buy) technical
"the 7,000-share option transaction reported for November 16, 2026"
vested technical
"option shares vested in equal monthly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AMBQ shares did Scott McLean Hanson sell, and were they under a trading plan?

Scott McLean Hanson sold 7,000 shares under a Rule 10b5-1 plan on November 16, 2026; the plan was adopted May 15, 2026. The sales were reported in three entries: 4,084 shares at a weighted average price of $43.848, 2,900 at a weighted average price of $44.2921, and 16 at $45.12.

What option exercise did Ambiq Micro's CTO report?

He exercised options for 7,000 common shares at $8.12 per share on November 16, 2026. The reported option position following the transaction was 31,279 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hanson Scott McLean

(Last)(First)(Middle)
C/O AMBIQ MICRO, INC.
6500 RIVER PLACE BLVD BUILDING 7 STE 200

(Street)
AUSTIN TEXAS 78730

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ambiq Micro, Inc. [ AMBQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026M(1)7,000A$8.12219,546D
Common Stock11/16/2026S(1)4,084D$43.848(2)215,462D
Common Stock11/16/2026S(1)2,900D$44.2921(3)212,562D
Common Stock11/16/2026S(1)16D$45.12212,546D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.1211/16/2026M(1)7,000 (4)10/01/2028Common Stock7,000$031,279D
Explanation of Responses:
1. The transactions reported in this Form 4 occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026.
2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.11 to $44.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.11 to $44.71 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. 1/4 of the shares subject to the option vested on August 16, 2019, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.
/s/ Jeffrey Winzeler, Attorney-in-Fact11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading